These activities were planned in collaboration with the Council of Medical Specialty Societies (CMSS) and the Federation of State Medical Boards (FSMB).
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
CNE Contact Hours: 2, all of which are pharmacology credit-worthy
This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study and opioid education. Several states have similar requirements. Please check with your Board to determine if this activity will fulfill your state's specific requirements.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for opioid education.
The AAFP has reviewed SCOPE of Pain: Safer/Competent Opioid Prescribing Education and deemed it acceptable for up to 2.00 Enduring Materials, Self-Study AAFP Prescribed credit. Term of Approval is from 03/01/2021 to 03/01/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education Information The University of Rhode Island, College of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of the entire online program and completion of online evaluations and self-assessment tools at the conclusion of the program are required for reporting continuing education credit to the National Association of Boards of Pharmacy via the CPE Monitor. This is a knowledge based learning activity.
Universal activity number: 0060-9999-21-044-H08-P
Contact hours: 2.00 Contact Hours (0.200 CEUs)
Initial Release Date: 10/1/2021
Planned Expiration Date: 9/30/2022
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate and de-identified data is shared with the commercial supporters.
Through the American Board of Medical Specialties (ABMS) ongoing commitment to increase access to practice relevant Maintenance of Certification (MOC) Activities through the ABMS Continuing Certification Directory, SCOPE of Pain has met the requirements as an MOC Part II Self-Assessment and/or MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
Note: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board's general CME requirement (only). Please refer directly to your Member Boards' MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
In order to receive credit, participants must review the activity content and complete the post-tests and evaluation for the two one-hour modules included within the activity. Participants who receive a cumulative grade of 70% or greater on the post-tests will receive credit. BOTH of the one-hour modules must be completed in order to earn your online certificate of credit. There will also be an online follow-up survey that will be distributed two months after completion of the program in order to further measure participant's changes in knowledge and behavior.
Date of Release: 3/1/2019
Date of most recent review: 9/30/2021
Date of Expiration: 9/30/2022
Physicians, nurse practitioners, registered nurses, physician assistants, nurses, dentists, pharmacists, and allied health professionals whose practices manage acute and chronic pain.
At the conclusion of these activities, participants will be better able to:
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
This activity does include discussion of the off-label use of sublingual buprenorphine to treat pain. Sublingual buprenorphine has been FDA approved for addiction treatment but not pain treatment. This presentation does include discussion of the off-label use of clonidine and tizanidine to treat opioid withdrawal symptoms. Clonidine and tizanidine are not FDA approved for this use.
Faculty members and planning committee members listed below have no relevant financial relationships to disclose.
Daniel P. Alford, MD, MPH, FACP
Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Jessica Taylor, MD
Assistant Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Ilana Hardesty, MA, Assistant Director, CME Operations, Boston University School of Medicine CME Office
Brian Jack, MD, independent AAFP reviewer
Patrick Kelly, PharmD, Senior Lecturer, University of Rhode Island College of Pharmacy
Jayne Pawasauskas, PharmD, BCPS, ACPE Course Advisor, Clinical Professor, University of Rhode Island College of Pharmacy
Carmela Townsend, DNP, MS/MBA, RN, Lead Nurse Planner, Boston University School of Medicine CME Office
Kristin Wason, MSN, NP-C, CARN, CNE Course Advisor, Boston University School of Medicine CME Office
Jason Worcester, MD, independent CME reviewer
Stephen A. Wyatt, DO, independent CME reviewer
Planning Committee members have nothing to disclose with regard to commercial support.
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration.
SCOPE of Pain
© 2021 Trustees of Boston University. Site by Signal.